CCR5 drives NK cell–associated airway damage in pulmonary ischemia-reperfusion injury
Primary graft dysfunction (PGD) limits clinical benefit after lung transplantation, a life-prolonging therapy for patients with end-stage disease. PGD is the clinical syndrome resulting from pulmonary ischemia-reperfusion injury (IRI), driven by innate immune inflammation. We recently demonstrated a...
| Published in: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
American Society for Clinical investigation
2023-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1172/jci.insight.173716 |
